Zetia (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the Zetia drug offered from Merck Sharp & Dohme Corp.. This Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | Ezetimibe |
SUBSTANCE NAME: | EZETIMIBE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2002-10-25 |
END MARKETING DATE: | 0000-00-00 |
Zetia HUMAN PRESCRIPTION DRUG Details:
Item Description | Zetia from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2002-10-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66582-414_7e4a2893-1fea-4609-828e-c69f147fde57 |
PRODUCT NDC: | 66582-414 |
APPLICATION NUMBER: | NDA021445 |
Other EZETIMIBE Pharmaceutical Manufacturers / Labelers: